Inactive Instrument

Analyst Reco. The Valens Company Inc.

Equities

The Valens Company Buy Rating Reiterated at Stifel GMP Following FQ3 Results; Price Target Kept at C$1.20	22-10-14	MT
The Valens Company Keep Buy Rating From BMO Capital Ahead of Acquistion by SNDL; Price Target Cut to C$1.20	22-08-23	MT
The Valens Company Reiterated at Buy at Stifel GMP Following Fiscal Second-Quarter Results	22-07-15	MT
The Valens Company Buy Rating Maintained at Stifel GMP Following Fiscal Second-Quarter Results	22-07-14	MT
VALENS : Shares Decline More than 4%, Desjardins Says EBITDA Positive Timeline Now Q2 Fiscal 2022	21-10-15	MT

No results for this search